|
| Press Releases |
|
 |
|
| Friday, August 15, 2025 |
|
|
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2025 (the 'Period'), reporting growth in both revenue and net profit despite an uncertain macroeconomic landscape. more info >> |
|
|
業聚醫療2025年中期業績收入及純利雙雙增長 分別達8,360萬美元及1,980萬美元 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球醫療器械製造公司業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至2025年6月30日止六個月(「報告期」)的中期業績。儘管宏觀經濟環境未見明朗，集團的收入及純利仍雙雙錄得增長。 more info >> |
|
|
业聚医疗2025年中期业绩收入及纯利双双增长 分别达8,360万美元及1,980万美元 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球医疗器械制造公司业聚医疗集团控股有限公司（"业聚医疗"或"集团"；股份代号：6929）今天宣布截至2025年6月30日止六个月("报告期")的中期业绩。尽管宏观经济环境未见明朗，集团的收入及纯利仍双双录得增长。 more info >> |
|
| Friday, March 7, 2025 |
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its annual results for the year ended December 31, 2024 (the 'Year'), reporting record-high revenue and healthy net profit despite the challenging business landscape. more info >> |
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至截至2024年12月31日止年度（「年度」）的全年業績。 more info >> |
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（“业聚医疗”或“集团”；股份代号：6929）今天宣布截至截至2024年12月31日止年度（“年度”）的全年业绩。 more info >> |
|
| Friday, August 16, 2024 |
|
|
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024 |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2024 (the 'Reporting Period), with revenue and profit for the period attributable to owners of the Company maintained at US$78.9 million and US$18.8 million respectively despite various market challenges. more info >> |
|
|
业聚医疗2024年上半年纯利达1,880万美元 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」；股份代号：6929）今天宣布截至2024年6月30日止六个月(「报告期」)的中期业绩。 more info >> |
|
|
業聚醫療2024年上半年純利達1,880萬美元 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至2024年6月30日止六個月(「報告期」)的中期業績。 more info >> |
|
| Wednesday, April 24, 2024 |
|
|
业聚医疗合资企业在中国内地启动TricValve临床试验 |
| more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Graphene Manufacturing Group Ltd. Announces Upsize of Bought Deal Public Offering for Gross Proceeds of C$6 Million
Aug 22, 2025 23:00 HKT/SGT
|
|
|
祖龍娱乐發佈2025年中期業績
Aug 22, 2025 22:11 HKT/SGT
|
|
|
祖龙娱乐发布2025年中期业绩
Aug 22, 2025 21:44 HKT/SGT
|
|
|
Ta Yang Group Holdings Limited Announcing AI Transformation Blueprint
Aug 22, 2025 19:21 HKT/SGT
|
|
|
CaoCao Inc. (2643.HK) Added to Hang Seng Composite Index, Set to Join Hong Kong Stock Connect on Sept 8
Aug 22, 2025 19:51 JST
|
|
|
CITIC Resources Deepens Dual Driver Development Strategy of "Investment + Trading"
Aug 22, 2025 19:28 JST
|
|
|
中信資源深化「投資+貿易」雙輪驅動發展戰略
Aug 22, 2025 18:21 HKT/SGT
|
|
|
中信资源深化"投资+贸易"双轮驱动发展战略
Aug 22, 2025 18:07 HKT/SGT
|
|
|
高端PCB龍頭勝宏科技衝刺港股 蓄勢AI時代新機遇
Aug 22, 2025 17:44 HKT/SGT
|
|
|
高端PCB龙头胜宏科技冲刺港股 蓄势AI时代新机遇
Aug 22, 2025 17:10 HKT/SGT
|
|
|
Everbright Grand China Achieved Revenue of RMB24.5 Million in 2025 1H
Aug 22, 2025 13:26 HKT/SGT
|
|
|
光大永年上半年收入人民幣24.5百萬元 派中期股息每股普通股人民幣0.73分
Aug 22, 2025 13:16 HKT/SGT
|
|
|
光大永年上半年收入人民币24.5百万元 派中期股息每股普通股人民币0.73分
Aug 22, 2025 13:05 HKT/SGT
|
|
|
China International Development Corporation acquires strategic 20% stake in NVT
Aug 22, 2025 9:22 JST
|
|
|
中聯發展控股集團有限公司宣布戰略收購NVT 20%股權
Aug 22, 2025 08:22 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
